4.6 Article

Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease

Journal

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 35, Issue 3, Pages 359-362

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/jcbfm.2014.224

Keywords

Alzheimer's; arterial spin labelling; cerebral vascular reactivity; MRI; tau

Funding

  1. Medical Research Council [MR/J013110/1, MR/1500422/1]
  2. NC3Rs [NC/K500276/1]
  3. Eli Lilly
  4. Medical Research Council [MR/J013110/1, G0601056] Funding Source: researchfish
  5. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/K500276/1] Funding Source: researchfish
  6. MRC [MR/J013110/1, G0601056] Funding Source: UKRI

Ask authors/readers for more resources

Vascular abnormalities are a key feature of Alzheimer's disease (AD). Imaging of cerebral vascular reactivity (CVR) is a powerful tool to investigate vascular health in clinical populations although the cause of reduced CVR in AD patients is not fully understood. We investigated the specific role of tau pathology in CVR derangement in AD using the rTg4510 mouse model. We observed an increase in CVR in cortical regions with tau pathology. These data suggest that tau pathology alone does not produce the clinically observed decreases in CVR and implicates amyloid pathology as the dominant etiology of impaired CVR in AD patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available